Search Results

There are 7144 results for: content related to: Milestones in movement disorders clinical trials: Advances and landmark studies

  1. (–)Deprenyl-Medication: A Strategy To Modulate the Age-Related Decline of the Striatal Dopaminergic System

    Journal of the American Geriatrics Society

    Volume 40, Issue 8, August 1992, Pages: 839–847, József Knoll

    Article first published online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1992.tb01860.x

  2. Assessing the Effects of Deprenyl on Longevity and Antioxidant Defenses in Different Animal Models

    Annals of the New York Academy of Sciences

    Volume 854, Issue 1, November 1998, Pages: 291–306, KENICHI KITANI, SETSUKO KANAI, GWEN O. IVY and MARIA CRISTINA CARRILLO

    Article first published online : 7 FEB 2006, DOI: 10.1111/j.1749-6632.1998.tb09910.x

  3. You have free access to this content
    Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish

    Journal of Neurochemistry

    Volume 109, Issue 2, April 2009, Pages: 403–415, Ville Sallinen, Maria Sundvik, Ilkka Reenilä, Nina Peitsaro, Denis Khrustalyov, Oleg Anichtchik, Gabija Toleikyte, Jan Kaslin and Pertti Panula

    Article first published online : 13 FEB 2009, DOI: 10.1111/j.1471-4159.2009.05986.x

  4. You have free access to this content
    Cytochrome P450-dependent metabolism of l-deprenyl in monkey (Cercopithecus aethiops) and C57BL/6 mouse brain microsomal preparations

    Journal of Neurochemistry

    Volume 86, Issue 5, September 2003, Pages: 1174–1180, Dragoni Stefania, Bellik Lydia, Frosini Maria, Matteucci Giacomo, Sgaragli Giampietro and Valoti Massimo

    Article first published online : 28 JUL 2003, DOI: 10.1046/j.1471-4159.2003.01927.x

  5. Effect of MAO-B Inhibitors on MPP+ Toxicity in Vivo

    Annals of the New York Academy of Sciences

    Volume 899, Issue 1, January 2000, Pages: 255–261, RUEY-MEEI WU, RONG-CHI CHEN and CHUANG C. CHIUEH

    Article first published online : 25 JAN 2006, DOI: 10.1111/j.1749-6632.2000.tb06191.x

  6. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: A randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial

    Annals of Neurology

    Volume 51, Issue 5, May 2002, Pages: 604–612, Ira Shoulson, David Oakes, Stanley Fahn, Anthony Lang, J. William Langston, Peter LeWitt, C. Warren Olanow, John B. Penney, Caroline Tanner, Karl Kieburtz and Alice Rudolph

    Article first published online : 23 APR 2002, DOI: 10.1002/ana.10191

  7. In vivo evaluation in cynomolgus monkey brain and metabolism of [18F]fluorodeprenyl: A new MAO-B pet radioligand

    Synapse

    Volume 66, Issue 4, April 2012, Pages: 323–330, Sangram Nag, Andrea Varrone, MiklÓs TÓth, Andrea Thiele, Georg Kettschau, Tobias Heinrich, Lutz Lehmann and Christer Halldin

    Article first published online : 30 DEC 2011, DOI: 10.1002/syn.21514

  8. Monoamine oxidase: radiotracer chemistry and human studies

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 58, Issue 3, March 2015, Pages: 51–64, Joanna S. Fowler, Jean Logan, Elena Shumay, Nelly Alia-Klein, Gene-Jack Wang and Nora D. Volkow

    Article first published online : 10 FEB 2015, DOI: 10.1002/jlcr.3247

  9. Neuroprotection in Parkinson's disease: Clinical trials

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S87–S99, Fabrizio Stocchi and C. Warren Olanow

    Article first published online : 24 MAR 2003, DOI: 10.1002/ana.10488

  10. Putative Interventions

    Standard Article

    Comprehensive Physiology

    Byung P. Yu

    Published Online : 1 JAN 2011, DOI: 10.1002/cphy.cp110123

  11. Pharmacological Interventions in Aging and Age-associated Disorders

    Annals of the New York Academy of Sciences

    Volume 959, Issue 1, April 2002, Pages: 295–307, KENICHI KITANI, CHIYOKO MINAMI, TAKAKO YAMAMOTO, SETSUKO KANAI, GWEN O. IVY and MARIA-CRISTINA CARRILLO

    Article first published online : 24 JAN 2006, DOI: 10.1111/j.1749-6632.2002.tb02101.x

  12. L-Deprenyl in the Treatment of Mild Dementia of the Alzheimer Type: Results of a 15–Month Trial

    Journal of the American Geriatrics Society

    Volume 41, Issue 11, November 1993, Pages: 1219–1225, Dr. William J. Burke, William H. Roccaforte, Steven P. Wengel, Barbara L. Bayer, Anthony E. Ranno and Nancy K. Willcockson

    Article first published online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1993.tb07306.x

  13. Do Antioxidant Strategies Work against Aging and Age-associated Disorders?

    Annals of the New York Academy of Sciences

    Volume 928, Issue 1, April 2001, Pages: 248–260, Kenichi Kitani, Chiyoko Minami, Takako Yamamoto, Wakako Maruyama, Setsuko Kanai, Gwen O. Ivy and Maria-Cristina Carrillo

    Article first published online : 25 JAN 2006, DOI: 10.1111/j.1749-6632.2001.tb05654.x

  14. You have free access to this content
    Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig

    British Journal of Pharmacology

    Volume 130, Issue 8, August 2000, Pages: 1992–1998, T Ilani, I Lamensdorf and J P M Finberg

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0703493

  15. Rescue of Dying Neurons by (R)-Deprenyl in the MPTP-Mouse Model of Parkinson's Disease Does Not Include Restoration of Neostriatal Dopamine

    Annals of the New York Academy of Sciences

    Volume 939, Issue 1, June 2001, Pages: 330–339, STEFANUS J. STEYN, KAY CASTAGNOLI and NEAL CASTAGNOLI JR.

    Article first published online : 25 JAN 2006, DOI: 10.1111/j.1749-6632.2001.tb03642.x

  16. You have free access to this content
    (−)1-(Benzofuran-2-yl)-2-propylaminopentane, [(−)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain

    British Journal of Pharmacology

    Volume 128, Issue 8, December 1999, Pages: 1723–1732, Joseph Knoll, Fumio Yoneda, Berta Knoll, Hironori Ohde and Ildikó Miklya

    Article first published online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0702995

  17. You have free access to this content
    Striatal Dopamine Metabolism in Monoamine Oxidase B-Deficient Mice : A Brain Dialysis Study

    Journal of Neurochemistry

    Volume 73, Issue 6, December 1999, Pages: 2434–2440, Francesco Fornai, Kevin Chen, Filippo Sean Giorgi, Marco Gesi, Maria Grazia Alessandri and Jean Chen Shih

    Article first published online : 18 JAN 2002, DOI: 10.1046/j.1471-4159.1999.0732434.x

  18. L-Deprenyl in the Treatment of Mild Dementia of the Alzheimer Type: Preliminary Results

    Journal of the American Geriatrics Society

    Volume 41, Issue 4, April 1993, Pages: 367–370, William J. Burke, Anthony E. Ranno, William H. Roccaforte, Steven P. Wengel, Barbara L. Bayer and Nancy K. Willcockson

    Article first published online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1993.tb06942.x

  19. You have free access to this content
    The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B

    British Journal of Pharmacology

    Volume 154, Issue 1, May 2008, Pages: 226–233, L P Quinn, B Crook, M E Hows, M Vidgeon-Hart, H Chapman, N Upton, A D Medhurst and D J Virley

    Article first published online : 29 JAN 2009, DOI: 10.1038/bjp.2008.78

  20. You have free access to this content
    Protection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells

    Journal of Neurochemistry

    Volume 76, Issue 3, February 2001, Pages: 650–660, Luigi A. De Girolamo, Alan J. Hargreaves and E. Ellen Billett

    Article first published online : 7 JUL 2008, DOI: 10.1046/j.1471-4159.2001.00066.x